Log In
BCIQ
Print this Print this
 

Opegan, sodium hyaluronate

  Manage Alerts
Collapse Summary General Information
Company Seikagaku Corp.
DescriptionHyaluronic acid formulation
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsUsed during ophthalmic surgery
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today